Posts by Sandra Ansanay-Alex
cellvie and CSEM Automate Mitochondrial Isolation to Enable Breakthrough Therapies
cellvie, a pioneer in harnessing the therapeutic potential of mitochondria, is developing a novel treatment for ischemia-reperfusion injuries – a condition affecting over 3 million patients annually in Europe and the U.S, in partnership with CSEM Ischemia-reperfusion injuries occur when blood supply returns to tissue after being restricted, causing extensive damage. They are linked…
Read MoreFIF Funding Supports Four Life Sciences Startups: Reverso Therapeutics, Harantech, Vibrant and Joipaw
Four innovative startups from Geneva developing solutions in pet health, life sciences, and digital therapeutics have received support from the FONGIT Innovation Fund (FIF). Harantech and Reverso Therapeutics, both UNIGE spin-offs, along with Vibrant, a Wyss Center project, each received a CHF 50,000 FIF Grant to support the translation of their research into tangible health…
Read MoreApertus: A New Opportunity for Swiss Health Valley and Healthcare Innovation
Created through a collaboration between EPFL, ETH Zurich, and the Swiss National Supercomputing Centre (CSCS), Apertus is more than just a technical achievement. It represents a strategic opportunity for the Swiss Health Valley, offering a trusted, transparent, and sovereign foundation for the integration of AI in life sciences and healthcare. A Truly Open AI…
Read MoreHevelion, IRIS and Kymansis awarded by the FIT
The Fondation pour l’Innovation Technologique awards three life sciences projects from CHUV and EPFL: Hevelion from UNIL-CHUV, and IRIS and Kymansis from EPFL. They received CHF 100’000 Tech Grants to continue developing their technologies. Hevelion: spatial omics for new targeted therapies Hevelion is developing an AI-powered software platform to accelerate spatial biomarker discovery for…
Read MoreAntoine Geissbühler, President of BioAlps, Receives Prestigious International Award
BioAlps is proud to celebrate its President, Professor Antoine Geissbühler, who has been awarded the François Grémy Award of Excellence by the International Medical Informatics Association (IMIA). This distinction, granted every two years, honors leaders who have made outstanding contributions to the field of medical informatics worldwide. Professor Antoine Geissbühler shares this year’s honor…
Read MoreCSEM Single-Cell Omics Workshop
The CSEM Single Cell Omics Workshop is taking place on 2 December 2025 at Aquatis Hotel in Lausanne Next-gen single-cell omics workshop, is a one-day event at the forefront of bioconvergence that brings together pioneers and innovators from the pharma and biotech industries, clinical practice, start-ups, regulation, and research. Single-cell technologies are revolutionizing complex 3D…
Read MoreWho You Inherit From Matters: New Genetic Study Uncovers Parent-Specific Effects
A groundbreaking study led by the SIB Statistical Genetics Group (University of Lausanne and Unisanté) reveals that the same genetic variant can affect traits like height, metabolism, and disease risk differently depending on whether it’s inherited from the mother or father. Using a new computational method, researchers analyzed DNA from over 236,000 individuals across…
Read MoreSNSF – Starting Grant
Apply before from 1 February until 5 May 2026 for the Swiss National Science Foundation Starting Grant SNSF Starting Grants 2025 represent the SNSF’s highest level of career funding. The call enables researchers to carry out their own independent project and lead a research team in Switzerland. Applicants must have several years of research…
Read MoreThe Origin of Astrocytes Revealed
A major discovery in neuroscience: a study from the Faculty of Medicine (FacMed) and the Synapsy Center at the University of Geneva uncovers that cortical astrocytes originate from two distinct progenitor cell types. Long considered a uniform support cell population, astrocytes are now recognized as diverse and essential players in brain function, involved in…
Read MoreNovochizol’s AgrINovo Partnership: Swiss-Indian Alliance for Agricultural Innovation
Indian company Aquagri, its partner, and Novochizol SA, a Valais-based startup, announced the launch of AgrINovo, a transformative collaborative project. AgrINovo aims to unlock the full potential of Novochizol technology to foster a healthier, more sustainable agriculture in India and worldwide. Novochizol™ is derived from chitosan, made from chitin, the second most abundant polysaccharide…
Read More